Wouters R - Search Results

1

CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression.

Riva M, Wouters R, Weerasekera A, Belderbos S, Nittner D, Thal DR, Baert T, Giovannoni R, Gsell W, Himmelreich U, Van Ranst M, Coosemans A. Riva M, et al. Among authors: wouters r. Biol Open. 2019 Sep 12;8(9):bio044552. doi: 10.1242/bio.044552. Biol Open. 2019. PMID: 31511246 Free PMC article.

2

Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer.

Coosemans AN, Baert T, D'Heygere V, Wouters R, DE Laet L, VAN Hoylandt A, Thirion G, Ceusters J, Laenen A, Vandecaveye V, Vergote I. Coosemans AN, et al. Among authors: wouters r. Anticancer Res. 2019 Nov;39(11):5953-5962. doi: 10.21873/anticanres.13800. Anticancer Res. 2019. PMID: 31704820

3

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study.

Vankerckhoven A, Wouters R, Mathivet T, Ceusters J, Baert T, Van Hoylandt A, Gerhardt H, Vergote I, Coosemans A. Vankerckhoven A, et al. Among authors: wouters r. Cells. 2020 Jan 27;9(2):305. doi: 10.3390/cells9020305. Cells. 2020. PMID: 32012728 Free PMC article.

4

Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas.

Riva M, Wouters R, Nittner D, Ceusters J, Sterpin E, Giovannoni R, Himmelreich U, Gsell W, VAN Ranst M, Coosemans A. Riva M, et al. Among authors: wouters r. J Neurosurg Sci. 2023 Feb;67(1):55-65. doi: 10.23736/S0390-5616.20.05060-2. Epub 2020 Oct 15. J Neurosurg Sci. 2023. PMID: 33056947

5

Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma.

Riva M, Wouters R, Sterpin E, Giovannoni R, Boon L, Himmelreich U, Gsell W, Van Ranst M, Coosemans A. Riva M, et al. Among authors: wouters r. Neurosurgery. 2021 Jan 13;88(2):E205-E215. doi: 10.1093/neuros/nyaa421. Neurosurgery. 2021. PMID: 33289503

6

Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma.

Wouters R, Bevers S, Riva M, De Smet F, Coosemans A. Wouters R, et al. Cancers (Basel). 2020 Dec 23;13(1):19. doi: 10.3390/cancers13010019. Cancers (Basel). 2020. PMID: 33374542 Free PMC article. Review.

7

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.

Sprooten J, Vankerckhoven A, Vanmeerbeek I, Borras DM, Berckmans Y, Wouters R, Laureano RS, Baert T, Boon L, Landolfo C, Testa AC, Fischerova D, Van Holsbeke C, Bourne T, Chiappa V, Froyman W, Schols D, Agostinis P, Timmerman D, Tejpar S, Vergote I, Coosemans A, Garg AD. Sprooten J, et al. Among authors: wouters r. J Immunother Cancer. 2021 Nov;9(11):e003609. doi: 10.1136/jitc-2021-003609. J Immunother Cancer. 2021. PMID: 34795003 Free PMC article.

8

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer.

De Bruyn C, Ceusters J, Landolfo C, Baert T, Thirion G, Claes S, Vankerckhoven A, Wouters R, Schols D, Timmerman D, Vergote I, Coosemans A. De Bruyn C, et al. Among authors: wouters r. Cancers (Basel). 2021 Nov 24;13(23):5899. doi: 10.3390/cancers13235899. Cancers (Basel). 2021. PMID: 34885008 Free PMC article.

9

Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model.

Wouters R, Westrøm S, Vankerckhoven A, Thirion G, Ceusters J, Claes S, Schols D, Bønsdorff TB, Vergote I, Coosemans A. Wouters R, et al. Pharmaceutics. 2022 Mar 22;14(4):687. doi: 10.3390/pharmaceutics14040687. Pharmaceutics. 2022. PMID: 35456521 Free PMC article.

10

Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis.

Wouters R, Vankerckhoven A, Verreet W, Ceusters J, Coosemans A. Wouters R, et al. Int J Gynecol Cancer. 2022 Dec 5;32(12):1583-1591. doi: 10.1136/ijgc-2022-003570. Int J Gynecol Cancer. 2022. PMID: 36028235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters